Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: POD1UM-303/InterAACT 2 - Retifanlimab + C-P in Untreated Inoperable or Metastatic Anal Squamous Cell Carcinoma
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Sheela Rao
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Sheela Rao
65 views
September 27, 2024
Comments 0
Login to view comments.
Click here to Login